No metabolites of neratinib were included in this partial validation (GLP) of neratinib in plasma ultracentrifugate by Covance. Six analytical batches were completed and accepted. Standard curves were linear from (LLOQ) 0.30 ng/mL to 30.0 ng/mL (mean r2 = 0.9996). Acceptable selectivity (i.e. ,